Microbot Medical Inc. cash flow to debt ratio of -1.51K% indicates that the company cannot generate enough cash to cover its debt over time. This level indicates weak financial health.

Microbot Medical Inc.'s free cash flow has decreased 48.06% from $-8.85M last year to $-13.11M, signaling decreasing performance

Microbot Medical Inc.'s debt to equity ratio is 0.01, which means that the company's assets are healthy financed, signaling financial stability.

Microbot Medical Inc.'s debt has decreased relative to shareholder equity from 0.03 last year to 0.01 today, signaling strengthened financials

Microbot Medical Inc. has a net cash position, so leverage is healthy.

Microbot Medical Inc. earns at least as much interest as it pays. Interest obligations are fully covered.

Microbot Medical Inc. has insufficient data to evaluate this check.

Microbot Medical Inc.'s short-term assets of $79.82M exceed its short-term liabilities of $3.42M

Microbot Medical Inc.'s return on assets of 0.00% is lower than the 5.00% threshold, indicating inefficient asset utilization

Microbot Medical Inc.'s return on equity of -13.59%, is lower than 15.00%, indicating bad performance

Microbot Medical Inc.'s operating cash flow is lower than its net income, indicating that earnings may not be fully backed by cash generation

Microbot Medical Inc. had positive net income in only 0 out of 5 years, indicating unstable earnings

Microbot Medical Inc. has negative free cash flow, indicating the company is burning cash rather than generating it

Microbot Medical Inc. has negative free cash flow, indicating cash burn

Microbot Medical Inc.'s yearly earnings has decreased 14.85% since last year from $-11.44M to $-13.14M, signaling decreasing performance

Microbot Medical Inc.'s yearly revenue has increased 0.00% since last year from $0.00 to $0.00, signaling increasing performance

ROIC -26.51% (Source: FMP key-metrics). Below the 5% partial-credit threshold. Score: 0 of 2. The 5% and 10% cutoffs anchor to typical US weighted-average cost of capital. Below 5% indicates the company is not generating returns above its likely cost of capital under this definition of invested capital. Invested capital here includes equity, non-current liabilities (pension obligations, deferred taxes, lease obligations), and short-term debt. Cash is not subtracted. Companies with substantial float, lease portfolios, or cash holdings will score lower under this definition than under narrower operating-capital definitions. See methodology.

Microbot Medical Inc. has insufficient revenue history to calculate 3-year revenue CAGR.

Microbot Medical Inc. had revenue growth in 5 out of 5 years, indicating consistent revenue performance

Microbot Medical Inc. had positive ROE in only 0 out of 5 years, indicating inconsistent returns on equity

Microbot Medical Inc. has insufficient data to evaluate this check.

Microbot Medical Inc. has negative trailing-twelve-month earnings; this ratio is not meaningful and the check fails

Microbot Medical Inc. is overvalued relative to its fair value price of 0.00 based on EBITDA multiple model

Microbot Medical Inc. has negative or missing EBITDA, making EV/EBITDA ratio unreliable

Microbot Medical Inc. has insufficient data to evaluate this check.

Microbot Medical Inc. has negative trailing-twelve-month earnings; this ratio is not meaningful and the check fails

Microbot Medical Inc. has a price-to-book ratio of 1.89x, which is below the 5.00x threshold, indicating reasonable valuation relative to its book value

Microbot Medical Inc. has a price-to-sales ratio of 999.00x, which exceeds the 8.00x threshold, indicating the stock may be overvalued relative to its revenue